1427 related articles for article (PubMed ID: 16019358)
1. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
2. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.
Heald A; Selby PL; White A; Gibson JM
Am J Obstet Gynecol; 2000 Sep; 183(3):593-600. PubMed ID: 10992179
[TBL] [Abstract][Full Text] [Related]
3. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
4. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
Duschek EJ; de Valk-de Roo GW; Gooren LJ; Netelenbos C
Fertil Steril; 2004 Aug; 82(2):384-90. PubMed ID: 15302288
[TBL] [Abstract][Full Text] [Related]
5. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
[TBL] [Abstract][Full Text] [Related]
6. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
[TBL] [Abstract][Full Text] [Related]
7. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
[TBL] [Abstract][Full Text] [Related]
8. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
[TBL] [Abstract][Full Text] [Related]
9. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
10. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
11. The IGF system in the neonatal ovine uterus.
Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
[TBL] [Abstract][Full Text] [Related]
12. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
13. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
14. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
[TBL] [Abstract][Full Text] [Related]
15. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
[TBL] [Abstract][Full Text] [Related]
16. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
17. Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy.
Raudaskoski T; Knip M; Laatikainen T
Menopause; 1998; 5(4):217-22. PubMed ID: 9872487
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs.
Carter AM; Kingston MJ; Han KK; Mazzuca DM; Nygard K; Han VK
J Endocrinol; 2005 Jan; 184(1):179-89. PubMed ID: 15642794
[TBL] [Abstract][Full Text] [Related]
19. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor-I system and hormone replacement therapy.
Cardim HJ; Lopes CM; Giannella-Neto D; da Fonseca AM; Pinotti JA
Fertil Steril; 2001 Feb; 75(2):282-7. PubMed ID: 11172828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
